William P. Quinn - 27 Feb 2023 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Chief Financial Officer
Signature
/s/ William P. Quinn
Issuer symbol
BOLT
Transactions as of
27 Feb 2023
Transactions value $
$0
Form type
4
Date filed
28 Feb 2023, 15:28
Previous filing
07 Feb 2023
Next filing
13 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLT Stock Option (Right to Buy) Award $0 +250K $0.00 250K 27 Feb 2023 Common Stock 250K $1.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023.